Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

NCT04138381 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Maximum Tolerated Dose
GIST
Metastatic Adult Soft Tissue Sarcoma
Drug Toxicity
Drug Use

Interventions

DRUG: Selinexor
DRUG: Imatinib

Sponsor

Grupo Espanol de Investigacion en Sarcomas